Literature DB >> 31679051

Expanded carrier screening: counseling and considerations.

Teresa N Sparks1.   

Abstract

The primary goal of carrier screening is to identify asymptomatic individuals who carry variants associated with genetic diseases, to inform about the risk of having a child with a genetic disease. Carrier screening can be accomplished through different approaches including ethnicity-based screening, pan-ethnic screening, and expanded carrier screening (ECS), and the decision to pursue carrier screening is voluntary. ECS takes a broad approach by screening for a large number of genetic diseases irrespective of ethnic background, and ideally is performed prior to conception. ECS has many benefits, including that it does not depend on accuracy of reported ancestry, as well as its greater yield of information that can be used for reproductive decision-making. However, there are also many important limitations of ECS to consider, ranging from the yield of unexpected information, uncertainty about the phenotype of a particular disease for which an individual is a carrier, and greater downstream costs associated with further testing and genetic counseling. Detailed genetic counseling both prior to and after ECS is essential in order for patients to understand the breadth of this approach, potential and actual results, and limitations.

Entities:  

Mesh:

Year:  2019        PMID: 31679051      PMCID: PMC7195224          DOI: 10.1007/s00439-019-02080-y

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  22 in total

1.  Where to Draw the Boundaries for Prenatal Carrier Screening.

Authors:  Wayne W Grody
Journal:  JAMA       Date:  2016-08-16       Impact factor: 56.272

2.  Modeled Fetal Risk of Genetic Diseases Identified by Expanded Carrier Screening.

Authors:  Imran S Haque; Gabriel A Lazarin; H Peter Kang; Eric A Evans; James D Goldberg; Ronald J Wapner
Journal:  JAMA       Date:  2016-08-16       Impact factor: 56.272

3.  Finding Middle Ground in Constructing a Clinically Useful Expanded Carrier Screening Panel.

Authors:  Blair Stevens; Nevena Krstic; Malorie Jones; Lauren Murphy; Jennifer Hoskovec
Journal:  Obstet Gynecol       Date:  2017-08       Impact factor: 7.661

4.  Patient perspectives on the use of categories of conditions for decision making about genomic carrier screening results.

Authors:  Stephanie A Kraft; Carmit K McMullen; Kathryn M Porter; Tia L Kauffman; James V Davis; Jennifer L Schneider; Katrina A B Goddard; Benjamin S Wilfond
Journal:  Am J Med Genet A       Date:  2017-12-18       Impact factor: 2.802

5.  Committee Opinion No. 691: Carrier Screening for Genetic Conditions.

Authors: 
Journal:  Obstet Gynecol       Date:  2017-03       Impact factor: 7.661

6.  Obstetricians and gynecologists' practice and opinions of expanded carrier testing and noninvasive prenatal testing.

Authors:  Peter Benn; Audrey R Chapman; Kristine Erickson; Mark S Defrancesco; Louise Wilkins-Haug; James F X Egan; Jay Schulkin
Journal:  Prenat Diagn       Date:  2013-12-16       Impact factor: 3.050

7.  Comparing ethnicity-based and expanded carrier screening methods at a single fertility center reveals significant differences in carrier rates and carrier couple rates.

Authors:  Alexandra Peyser; Tomer Singer; Christine Mullin; Sara L Bristow; Amber Gamma; Kenan Onel; Avner Hershlag
Journal:  Genet Med       Date:  2018-10-16       Impact factor: 8.822

8.  Responsible implementation of expanded carrier screening.

Authors:  Lidewij Henneman; Pascal Borry; Davit Chokoshvili; Martina C Cornel; Carla G van El; Francesca Forzano; Alison Hall; Heidi C Howard; Sandra Janssens; Hülya Kayserili; Phillis Lakeman; Anneke Lucassen; Sylvia A Metcalfe; Lovro Vidmar; Guido de Wert; Wybo J Dondorp; Borut Peterlin
Journal:  Eur J Hum Genet       Date:  2016-03-16       Impact factor: 4.246

9.  "Is It Worth Knowing?" Focus Group Participants' Perceived Utility of Genomic Preconception Carrier Screening.

Authors:  Jennifer L Schneider; Katrina A B Goddard; James Davis; Benjamin Wilfond; Tia L Kauffman; Jacob A Reiss; Marian Gilmore; Patricia Himes; Frances L Lynch; Michael C Leo; Carmit McMullen
Journal:  J Genet Couns       Date:  2015-06-21       Impact factor: 2.537

Review 10.  Changing trends in carrier screening for genetic disease in the United States.

Authors:  Shivani B Nazareth; Gabriel A Lazarin; James D Goldberg
Journal:  Prenat Diagn       Date:  2015-07-27       Impact factor: 3.050

View more
  5 in total

Review 1.  Societal implications of expanded universal carrier screening: a scoping review.

Authors:  Lieke M van den Heuvel; Nina van den Berg; A Cecile J W Janssens; Erwin Birnie; Lidewij Henneman; Wybo J Dondorp; Mirjam Plantinga; Irene M van Langen
Journal:  Eur J Hum Genet       Date:  2022-09-12       Impact factor: 5.351

Review 2.  Ethical considerations in gene selection for reproductive carrier screening.

Authors:  Lisa Dive; Alison Dalton Archibald; Ainsley J Newson
Journal:  Hum Genet       Date:  2021-08-23       Impact factor: 5.881

3.  Special issue on "Feto-Maternal Genomic Medicine": a decade of incredible advances.

Authors:  Kathryn J Gray; Louise Wilkins-Haug
Journal:  Hum Genet       Date:  2020-09       Impact factor: 4.132

Review 4.  Ethical Issues in Care and Treatment of Neuronal Ceroid Lipofuscinoses (NCL)-A Personal View.

Authors:  Alfried Kohlschütter
Journal:  Front Neurol       Date:  2021-06-25       Impact factor: 4.003

Review 5.  Current Updates on Expanded Carrier Screening: New Insights in the Omics Era.

Authors:  Iolanda Veneruso; Chiara Di Resta; Rossella Tomaiuolo; Valeria D'Argenio
Journal:  Medicina (Kaunas)       Date:  2022-03-21       Impact factor: 2.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.